Target intelligence / Profile preview

Zinc finger protein 280B (ZNF280B)

Target
ZNF280B
Molecular classification
Transcription factor, Zinc finger protein, C2H2-type zinc finger protein
01

Overview

Zinc finger protein 280B (ZNF280B) is a member of the C2H2-type zinc finger transcription factor family, characterized by multiple zinc finger domains that facilitate DNA binding and regulation of gene expression[1][5]. As a transcription factor, ZNF280B is implicated in regulating cell proliferation and survival, especially in cancer contexts such as prostate and gastric cancers[1][2][3]. In prostate cancer, ZNF280B promotes tumor growth by up-regulating the expression of the Mdm2 gene, which in turn leads to degradation of the tumor suppressor protein p53 via enhanced proteasomal degradation—a key pro-survival and pro-growth mechanism in tumorigenesis[1]. In gastric cancer, increased ZNF280B expression is associated with larger tumor size, advanced stage, and increased proliferation, suggesting an oncogenic function[2][3]. The protein's exact mechanisms and broader physiological roles remain under investigation, but its effect on the Mdm2-p53 axis and correlation with cancer progression support its identification as a molecular target in oncology research[1][2].

Other names
Zinc finger protein 280BZNF280BSUHW2ZNF279ZNF632Suppressor of hairy wing homolog 2Zinc finger protein 279Zinc finger protein 632D87009.C22.35'OY11.1
02

Biological functions

Transcriptional regulation (acts as a potential transcriptional activator or repressor)[1][2][5]Regulation of cell proliferation[1][2][3]Regulation of apoptosis/cell survival[1][2]Modulation of p53 tumor suppressor pathway[1][2]Potential epigenetic regulation (similarity to UHRF1)[1]
03

Disease associations

Cancer (prostate cancer, gastric cancer, possibly other tumor types)[1][2][3]Potential tumor suppressor roles in certain hematologic malignancies (based on other zinc finger proteins)[2]
04

Biomarkers

Expression levels may serve as a biomarker for cancer cell proliferation (e.g., Ki-67 association in gastric cancer)[2]Potential biomarker for poor prognosis or advanced tumor stage in gastric cancer[2]

Beyond the preview

Go deeper on Zinc finger protein 280B (ZNF280B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 280B (ZNF280B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call